Header Logo

LINA MERJANEH

Concepts (65)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystic Fibrosis
4
2023
264
1.740
 Why?
Hyperglycemia
2
2023
235
1.270
 Why?
Vomiting
1
2021
108
0.670
 Why?
Autoantibodies
1
2022
456
0.610
 Why?
Polycystic Ovary Syndrome
1
2019
75
0.580
 Why?
Disease Progression
3
2023
2221
0.530
 Why?
Diabetes Mellitus, Type 2
4
2024
1410
0.480
 Why?
Hypopituitarism
1
2015
18
0.470
 Why?
Shock
1
2015
98
0.430
 Why?
Diabetes Mellitus
1
2022
923
0.430
 Why?
Prediabetic State
1
2014
64
0.410
 Why?
Insulin-Secreting Cells
1
2014
146
0.390
 Why?
Gastroenteritis
1
2015
365
0.380
 Why?
Diabetes Mellitus, Type 1
3
2024
861
0.320
 Why?
Glucose Tolerance Test
2
2020
206
0.260
 Why?
Adolescent
8
2024
20535
0.240
 Why?
Acute Disease
2
2020
1160
0.230
 Why?
Young Adult
6
2024
9952
0.220
 Why?
Insulin
2
2022
1168
0.210
 Why?
Blood Glucose Self-Monitoring
1
2023
124
0.190
 Why?
Hypoglycemia
1
2022
183
0.170
 Why?
Diabetic Ketoacidosis
1
2022
166
0.160
 Why?
Menstruation Disturbances
1
2019
16
0.160
 Why?
Hyperandrogenism
1
2019
25
0.150
 Why?
Child
5
2024
25761
0.150
 Why?
Vascular Stiffness
1
2020
81
0.150
 Why?
Blood Glucose
1
2023
1121
0.150
 Why?
Glucose
1
2023
870
0.150
 Why?
Monitoring, Physiologic
1
2020
377
0.140
 Why?
Humans
11
2024
131929
0.140
 Why?
Cholesterol, LDL
1
2020
606
0.130
 Why?
Combined Modality Therapy
1
2019
1293
0.120
 Why?
Thyroid Hormones
1
2015
56
0.120
 Why?
Hydrocortisone
1
2015
226
0.110
 Why?
Cardiovascular Diseases
2
2024
2091
0.110
 Why?
Prevalence
1
2020
2658
0.100
 Why?
Diagnosis, Differential
1
2019
1949
0.100
 Why?
Glucose Intolerance
1
2014
85
0.100
 Why?
Male
5
2024
64872
0.100
 Why?
Statistics, Nonparametric
1
2014
435
0.100
 Why?
Reference Values
1
2014
704
0.100
 Why?
Hormone Replacement Therapy
1
2015
211
0.100
 Why?
Practice Guidelines as Topic
1
2019
1299
0.090
 Why?
Incidence
2
2024
3375
0.090
 Why?
Age Factors
2
2020
2912
0.090
 Why?
Time Factors
1
2022
6440
0.090
 Why?
Cross-Sectional Studies
2
2022
3760
0.080
 Why?
Sex Factors
1
2014
1351
0.080
 Why?
Adult
3
2023
31538
0.080
 Why?
Pediatrics
1
2019
1211
0.080
 Why?
Comorbidity
1
2014
1605
0.080
 Why?
Female
4
2024
70586
0.080
 Why?
Risk Assessment
1
2014
3732
0.060
 Why?
Prognosis
1
2014
5007
0.060
 Why?
Forced Expiratory Volume
1
2023
173
0.050
 Why?
Adrenal Cortex Hormones
1
2023
339
0.040
 Why?
Diabetic Angiopathies
1
2020
71
0.040
 Why?
Age of Onset
1
2020
622
0.040
 Why?
Insulin Resistance
1
2020
698
0.030
 Why?
Prospective Studies
1
2023
6569
0.020
 Why?
Anti-Bacterial Agents
1
2023
2554
0.020
 Why?
Cohort Studies
1
2020
5163
0.020
 Why?
Risk Factors
1
2024
10933
0.020
 Why?
Retrospective Studies
1
2023
17374
0.010
 Why?
United States
1
2020
11648
0.010
 Why?
MERJANEH's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (65)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_